Expanded Access: Approved for Marketing
"Expanded access: approved for marketing" is when the intervention has been approved by the U.S. Food and Drug Administration for use by the public. (CTG) "
Support Provided by AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Genentech, Merck, and Sanofi.
